Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $2.2 million.

  • ProPhase Labs' Other Accumulated Expenses rose 3679.01% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 3679.01%. This contributed to the annual value of $2.1 million for FY2024, which is 1821.35% down from last year.
  • Per ProPhase Labs' latest filing, its Other Accumulated Expenses stood at $2.2 million for Q3 2025, which was up 3679.01% from $1.8 million recorded in Q2 2025.
  • ProPhase Labs' Other Accumulated Expenses' 5-year high stood at $9.8 million during Q1 2021, with a 5-year trough of $1.5 million in Q2 2022.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $2.1 million (2024), whereas its average is $3.0 million.
  • In the last 5 years, ProPhase Labs' Other Accumulated Expenses soared by 278964.5% in 2021 and then plummeted by 7557.56% in 2022.
  • Over the past 5 years, ProPhase Labs' Other Accumulated Expenses (Quarter) stood at $2.5 million in 2021, then decreased by 16.95% to $2.1 million in 2022, then grew by 24.81% to $2.6 million in 2023, then dropped by 18.21% to $2.1 million in 2024, then grew by 4.78% to $2.2 million in 2025.
  • Its Other Accumulated Expenses was $2.2 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.7 million in Q1 2025.